4//SEC Filing
McCubbin Quentin 4
Accession 0001127602-21-014293
CIK 0001703647other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 4:23 PM ET
Size
5.1 KB
Accession
0001127602-21-014293
Insider Transaction Report
Form 4
McCubbin Quentin
Chief Manufacturing Officer
Transactions
- Award
Restricted Stock Unit
2021-04-20+35,000→ 35,000 total→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001842009
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 4:23 PM ET
- Size
- 5.1 KB